SAI LIFE SCIENCES LTD
Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was … Read more
SAI LIFE SCIENCES LTD (SAILIFE) - Total Liabilities
Latest total liabilities as of September 2025: ₹10.62 Billion INR
Based on the latest financial reports, SAI LIFE SCIENCES LTD (SAILIFE) has total liabilities worth ₹10.62 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
SAI LIFE SCIENCES LTD - Total Liabilities Trend (2022–2025)
This chart illustrates how SAI LIFE SCIENCES LTD's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
SAI LIFE SCIENCES LTD Competitors by Total Liabilities
The table below lists competitors of SAI LIFE SCIENCES LTD ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
RF Capital Group Inc
PINK:GMPFF
|
USA | $1.06 Billion |
|
Suzhou Secote Precision Electronic Co Ltd Class A
SHG:603283
|
China | CN¥2.47 Billion |
|
PT Pantai Indah Kapuk Dua Tbk
JK:PANI
|
Indonesia | Rp19.33 Trillion |
|
Strathcona Resources Ltd.
PINK:STHRF
|
USA | $6.41 Billion |
|
American Assets Trust Inc
NYSE:AAT
|
USA | $1.83 Billion |
|
REalloys Inc.
NASDAQ:ALOY
|
USA | $3.03 Million |
|
Robertet SA
PINK:RBTEF
|
USA | $450.06 Million |
Liability Composition Analysis (2022–2025)
This chart breaks down SAI LIFE SCIENCES LTD's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.92 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SAI LIFE SCIENCES LTD's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SAI LIFE SCIENCES LTD (2022–2025)
The table below shows the annual total liabilities of SAI LIFE SCIENCES LTD from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹10.32 Billion | -20.64% |
| 2024-03-31 | ₹13.00 Billion | +0.11% |
| 2023-03-31 | ₹12.99 Billion | +1.00% |
| 2022-03-31 | ₹12.86 Billion | -- |